Low immunogenicity of vedolizumab determined by a simple drug-tolerant assay in patients with ulcerative colitis.

J Clin Biochem Nutr · 2022 · PMC8764101 · PMID 35068684

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

did not reach statistical significancep = 0.058so close (0.05 < p ≤ 0.1)

5 B), but this did not reach statistical significance ( p = 0.058).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.